Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88
Published July 23, 2025 · Recall initiated: June 16, 2025
Summary
FDA records drug Class II recall D-0516-2025, published July 23, 2025 and initiated June 16, 2025. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Ongoing; Reported quantity: 5,448 bottles; Lot: Lot # AD42648, Exp 02/28/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25®C, 60%RH).
What to do
Voluntary: Firm initiated · Letter
Get an email if LISDEXAMFETAMINE DIMESYLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
- Lot
- Lot # AD42648, Exp 02/28/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDATestosterone 200 mg Pellet packaged in 1mL amber vials, Rx only, Compounded product. Qualgen 14844 BristolJuly 23, 2025
- FDABrand Name: Canturio® Smart Extension Product Name: CSE Implant Model/Catalog Number: 43-5570-030-14 ProductJuly 16, 2025
Questions about this recall
Was Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88 recalled?
Yes. FDA published recall D-0516-2025 on July 23, 2025. Reported hazard: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25®C, 60%RH).
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LISDEXAMFETAMINE DIMESYLATE.